Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G2 checkpoint arrest

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 7, 2011, Pages 1528-1541

  Poehlmann, Angela ^a   Habold, Caroline ^a,b   Walluscheck, Diana ^a   Reissig, Kathrin ^a   Bajbouj, Khuloud ^a   Ullrich, Oliver ^a,c   Hartig, Roland ^a   Gali Muhtasib, Hala ^d   Diestel, Antje ^a,e   Roessner, Albert ^a   Schneider Stock, Regine ^a,f  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Institut Pluridisciplinaire Hubert Curien UMR 7178   (France)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Checkpoint kinase 1 (Chk1); DNA damage; G2 checkpoint; Mitotic catastrophe; Recovery; Senescence

Indexed keywords

CHECKPOINT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HYDROGEN PEROXIDE; OXIDIZING AGENT; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN P53;

ANIMAL; ARTICLE; CELL AGING; CELL CYCLE G2 PHASE; DNA DAMAGE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; G2 PHASE; HUMANS; HYDROGEN PEROXIDE; OXIDANTS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79959416307     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01143.x     Document Type: Article

References (43)

1. Shapiro GI, Harper JW. Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest. 1999; 104: 1645-53.
2. Schmitt E, Paquet C, Beauchemin M, et al DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis. J Zhejiang Univ Sci B. 2007; 8: 377-97.
3. Ozben T. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci. 2007; 96: 2181-96.
4. Coleman TR, Dunphy WG. Cdc2 regulatory factors. Curr Opin Cell Biol. 1994; 6: 877-82.
5. Krek W, Nigg EA. Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. EMBO J. 1991; 10: 3331-41.
6. Liu Q, Guntuku S, Cui XS, et al Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 2000; 14: 1448-59.
7. Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol. 2001; 21: 4129-39.
8. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000; 408: 433-9.
9. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004; 432: 316-23.
10. Peng CY, Graves PR, Thoma RS, et al Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 1997; 277: 1501-5.
11. Sanchez Y, Wong C, Thoma RS, et al Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science. 1997; 277: 1497-501.
12. Latif C, den Elzen NR, O'Connell MJ. DNA damage checkpoint maintenance through sustained Chk1 activity. J Cell Sci. 2004; 117: 3489-98.
13. den Elzen NR, O'Connell MJ. Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1. EMBO J. 2004; 23: 908-18.
14. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol. 2007; 19: 238-45.
15. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997; 88: 323-31.
16. Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat. 2001; 4: 303-13.
17. Lleonart ME, Artero-Castro A, Kondoh H. Senescence induction; a possible cancer therapy. Mol Cancer. 2009; in press: doi:.
18. Sarkisian CJ, Keister BA, Stairs DB, et al Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol. 2007; 9: 493-505.
19. Schmitt CA. Cellular senescence and cancer treatment. Biochim Biophys Acta. 2007; 1775: 5-20.
20. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene. 2004; 23: 2919-33.
21. Roninson IB. Tumor cell senescence in cancer treatment. Cancer Res. 2003; 63: 2705-15.
22. Castedo M, Perfettini JL, Roumier T, et al Cell death by mitotic catastrophe: a molecular definition. Oncogene. 2004; 23: 2825-37.
23. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ. 2008; 15: 1153-62.
24. Kuntz K, O'Connell MJ. The G(2) DNA damage checkpoint: could this ancient regulator be the achilles heel of cancer Cancer Biol Ther. 2009; 8: 1433-9.
25. Reinhardt HC, Yaffe MB. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol. 2009; 21: 245-55.
26. Habold C, Poehlmann A, Bajbouj K, et al Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. J Cell Mol Med. 2008; 12: 607-21.
27. Barbouti A, Doulias PT, Nousis L, et al DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H(2)O(2). Free Radic Biol Med. 2002; 33: 691-702.
28. Antunes F, Cadenas E. Estimation of H2O2 gradients across biomembranes. FEBS Lett. 2000; 475: 121-6.
29. Gali-Muhtasib H, Kuester D, Mawrin C, et al Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res. 2008; 68: 5609-18.
30. Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol. 1998; 141: 875-85.
31. Bassing CH, Chua KF, Sekiguchi J, et al Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci USA. 2002; 99: 8173-8.
32. Celeste A, Petersen S, Romanienko PJ, et al Genomic instability in mice lacking histone H2AX. Science. 2002; 296: 922-7.
33. Dumaz N, Meek DW. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 1999; 18: 7002-10.
34. Chang BD, Xuan Y, Broude EV, et al Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene. 1999; 18: 4808-18.
35. Bhonde MR, Hanski ML, Notter M, et al Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth. Oncogene. 2006; 25: 165-75.
36. Macip S, Kosoy A, Lee SW, et al Oxidative stress induces a prolonged but reversible arrest in p53-null cancer cells, involving a Chk1-dependent G2 checkpoint. Oncogene. 2006; 25: 6037-47.
37. Moran DM, Gawlak G, Jayaprakash MS, et al Geldanamycin promotes premature mitotic entry and micronucleation in irradiated p53/p21 deficient colon carcinoma cells. Oncogene. 2008; 27: 5567-77.
38. Gabai VL, O'Callaghan-Sunol C, Meng L, et al Triggering senescence programs suppresses Chk1 kinase and sensitizes cells to genotoxic stresses. Cancer Res. 2008; 68: 1834-42.
39. Banáth JP, Macphail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res. 2004; 64: 7144-9.
40. Gottifredi V, Karni-Schmidt O, Shieh SS, et al P53 down-regulates CHK1 through p21 and the Retinoblastoma protein. Mol Cell Biol. 2001; 21: 1066-76.
41. Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol. 1998; 141: 875-85.
42. Porter LA, Cukier IH, Lee JM. Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis. Blood. 2003; 101: 1928-33.
43. Rodrigues NR, Rowan A, Smith ME, et al p53 mutations in colorectal cancer. Proc Natl Acad Sci USA. 1990; 87: 7555-9.